Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.11, 2002-11, pp. : 1543-1556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors and AT-1-receptor antagonists COOPERATE in non-diabetic renal disease

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 7, 2003-07 ,pp. : 1185-1188

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin Antagonism in Patients with Heart Failure: ACE Inhibitors, Angiotensin Receptor Antagonists or Both?

By Nicholas L.M. Cruden   David E. Newby  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 345-353

Adis International

Access to resources Recommend Favorite

Efficacy of Angiotensin Receptor Blockers in Cardiovascular Disease

By Maggioni Aldo  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 4, 2006-08 ,pp. : 295-308

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control: Editorial to: “Secondary Prevention of Coronary Disease with ACE Inhibition—Does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?” by Remme et al.

By Verma Anil   Ventura Hector  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite

ACE inhibitors and angiotensin receptor blockers (ARBs) appear to be beneficial in patients with acute renal transplant failure

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite